| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
||||
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
October 21, 2004
Baxter International Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 1-4448 | 36-0781620 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| One Baxter Parkway, Deerfield, Illinois |
60015 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code
847.948.2000
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
EXPLANATORY NOTE: This Form 8-K/A is being filed solely to correct a typographical error in the schedule to the company’s press release dated October 21, 2004 entitled “Key Product Line Sales—US/International” which is on page 13 of Exhibit 99. The corrected schedule is filed with this Form 8-K/A, and indicates that the growth rate in the U.S. for Bioscience-Other was negative 47% for the third quarter of 2004, as compared to the third quarter of 2003 (not positive 47%).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| BAXTER INTERNATIONAL INC. | ||
| (Registrant) | ||
| By: | /s/ Jan Stern Reed | |
| Jan Stern Reed | ||
| Corporate Secretary | ||
Date: October 21, 2004
Exhibit Index
| Exhibit No. |
Description | |
| 99 | Corrected Schedule—Key Product Line Sales—US/International |